|
End-of-day quote
Bulgaria S.E.
2026-10-16
|
5-day change | 1st Jan Change | ||
| 2.920 EUR | +5.42% |
|
+11.45% | +104.98% |
| 09-21 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended August 2026 | CI |
| 08-28 | Sopharma AD Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 2.94B 1.77B 1.58B 1.46B 1.33B 2.49B 168B 2.53B 17.52B 6.89B 87.64B 6.64B 6.5B 280B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 3.49B 2.09B 1.87B 1.73B 1.57B 2.95B 199B 3B 20.74B 8.15B 104B 7.86B 7.69B 332B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | 5.02% |
Bulgaria S.E.EUR
| Markets | Quality | ||
|---|---|---|---|
Bulgaria S.E.
| SFA | End-of-day quote | |
Warsaw S.E.
| SPH | Delayed | |
|
Deutsche Boerse AG
| 3JR | Delayed |
| 1 day | +5.42% | ||
| 1 week | +11.45% | ||
| Current month | +12.74% | ||
| 1 month | +15.87% | ||
| 3 months | +54.50% | ||
| 6 months | +66.86% | ||
| Current year | +104.98% |
| 1 week | 2.61 |  | 2.95 |
| 1 month | 2.46 | | 2.95 |
| Current year | 1.41 | | 2.95 |
| 1 year | 1.34 | | 2.95 |
| 3 years | 0.94 | | 2.95 |
| 5 years | 0.65 | | 2.95 |
| 10 years | 0.41 | | 2.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 2000-09-30 |
Boris Borisov
DFI | Director of Finance/CFO | - | 2001-12-31 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 2010-05-18 |
| Director/Board Member | 63 | 2010-05-18 | |
| Director/Board Member | 61 | 2011-07-11 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 9/30/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 9/29/20 | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.42% | +11.45% | +112.35% | +146.20% | 1.77B | |
| +2.17% | +6.87% | -36.53% | +3.94% | 15.67B | |
| +17.11% | +3.97% | +12.63% | -16.93% | 7.07B | |
| +0.66% | +4.62% | -10.91% | +6.65% | 6.34B | |
| +0.77% | +3.55% | -11.51% | -1.44% | 6.34B | |
| +1.52% | +5.07% | -49.24% | -35.52% | 6.19B | |
| +1.16% | +5.49% | +2.71% | -8.25% | 4.54B | |
| -1.25% | +12.01% | -34.35% | -2.21% | 3.41B | |
| +0.02% | +1.05% | -14.02% | -8.96% | 3.24B | |
| +2.47% | +1.65% | +8.97% | -19.16% | 3.17B | |
| Average | +3.01% | +3.98% | -1.99% | +6.43% | 5.77B | |
| Weighted average by Cap. | +3.33% | +3.81% | -14.78% | -2.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.15B 1.06B 965M 1.81B 122B 1.84B 12.73B 5B 63.67B 4.82B 4.72B 204B | 2.63B 1.58B 1.41B 1.31B 1.19B 2.23B 150B 2.26B 15.66B 6.16B 78.35B 5.93B 5.81B 250B |
| Net income | 77.85M 46.75M 41.68M 38.61M 35.1M 65.87M 4.43B 66.95M 463M 182M 2.32B 175M 172M 7.41B | 134M 80.19M 71.48M 66.22M 60.21M 113M 7.6B 115M 794M 312M 3.97B 301M 295M 12.7B |
| Net Debt | 444M 267M 238M 220M 200M 376M 25.29B 382M 2.64B 1.04B 13.22B 1B 980M 42.26B | 541M 325M 290M 268M 244M 458M 30.82B 466M 3.22B 1.27B 16.11B 1.22B 1.19B 51.5B |
Employees
6,049
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | €2.920 | +5.42% | 139,942 |
| 26-10-15 | €2.770 | -0.72% | 15,112 |
| 26-10-14 | €2.790 | +5.68% | 89,107 |
| 26-10-13 | €2.640 | +0.76% | 28,254 |
| 26-10-12 | €2.620 | 0.00% | 7,884 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
